Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Crucell Terug naar discussie overzicht

Vaccination drive to replace Indian vials

209 Posts
Pagina: «« 1 ... 6 7 8 9 10 11 | Laatste | Omlaag ↓
  1. maxen 4 april 2010 11:46
    quote:

    patient schreef:

    [quote=patient]
    Antwoord van IR Crucell op mijn e-mail:
    [/quote]

    Met excuus voor de late plaatsing (aantal dagen weggeweest en geen mail opgehaald)
    ...
    Lees vooral ook pagina 15 van dit draadje even door ;-)

    Ook jij dank voor plaatsing!
  2. patient 4 april 2010 12:04
    quote:

    maxen schreef:

    [quote=patient]
    [quote=patient]
    Antwoord van IR Crucell op mijn e-mail:
    [/quote]

    Met excuus voor de late plaatsing (aantal dagen weggeweest en geen mail opgehaald)
    ...
    [/quote]
    Lees vooral ook pagina 15 van dit draadje even door ;-)

    Ook jij dank voor plaatsing!
    Bedankt voor je reactie!
    Blijkt wel weer dat je altijd scherp moet blijven!!
    Ik ga maar weer eitjes zoeken, hoop volgend jaar met Pasen wat produktieve cellijnen te vinden.;Q))
  3. forum rang 6 de tuinman 4 april 2010 17:02
    Vergeef me dat het me spijt als ik naar de bekende weg vraag, maar is er al iets bekend wanneer Unicef de volgende opdrachten bekend gaat maken?
  4. maxen 4 april 2010 17:27
    quote:

    de tuinman schreef:

    Vergeef me dat het me spijt als ik naar de bekende weg vraag, maar is er al iets bekend wanneer Unicef de volgende opdrachten bekend gaat maken?
    pagina 18:
    aossa - 2 apr 10, 13:52
  5. [verwijderd] 8 april 2010 19:05
    Fault vaccines to be replaced
    Wednesday, April 07,2010
    KATHMANDU: Nepal will replace faulty vaccines made by an Indian company with vaccines manufactured by Crucell Berna, a South Korean biopharmaceutical company, by April 12. Vaccines made by Shantha Biotech have been suspended in Nepal by the World Health Organization (WHO) because of manufacturing errors in the vaccines.

    According to an official of the Ministry of Health, Nepal will get as many as 131,000 vials of Quinvaxem, a pentavalent vaccines that protect infants from

    five diseases--Diphtheria, Whooping Cough, Tetanus, Hepatitis B, and Haemophilus Influenza B.

    “We will resume our vaccination drive after we get the vaccines,” Krishna Bahadur Chand, chief of the immunisation programme at Child Health Division under the Department of Health Services, said.

    Nepal’s vaccination drive has been halted since March 24 after WHO recommended to DoHS that it should not use vaccines manufactured by Shantha Biotech following complaints from different countries about faults in the vaccines’ composition.

    Chand also said that the National Committee for Immunisation Practices, a technical body that recommends the government on immunisation programmes, has already approved these new vaccines. Subsequently, the National Regulatory Authority, a government body that approves the procurement of new drugs, has also given a nod to this end.

    The vaccines manufactured by Shanta Biotech were introduced in Nepal in April last year. In the first phase, the vaccines were brought in use in 25 Far- and Mid-West districts. The second phase of the vaccination drive started in December and included the other 50 districts.

    “We have halted the immunisation drive that aimed at reducing infant mortality immediately after WHO made its recommendations, but we will continue as soon as the new vaccines enter the country,” said Dr. Praveen Misra, Secretary at the Ministry of Health.

    www.southasianmedia.net/cnn.cfm?id=64...
  6. forum rang 6 de tuinman 8 april 2010 21:24
    Dat vind ik nu het mooie van deze forum. Wij wisten dit al.

    In het eerste gedeelte van dit artikel praten ze over manufacturing errors.
    Lijkt me nogal een grote blunder.
  7. [verwijderd] 8 april 2010 23:46
    quote:

    de tuinman schreef:

    Dat vind ik nu het mooie van deze forum. Wij wisten dit al.

    In het eerste gedeelte van dit artikel praten ze over manufacturing errors.
    Lijkt me nogal een grote blunder.
    Het gaat om de details ! (vind de verschillen :))
  8. [verwijderd] 11 april 2010 20:31
    APR 10 -
    A little over a week ago, the government prohibited the use of the pentavalent vaccination after harmful ‘suspended particles’ were found in the vials imported into the country by the United Nations Children Fund (UNICEF) through another UN body, the World Health Organisation (WHO). The five-in-one vaccine is given to children under a year old to protect them against five potential killers — diphtheria, tetanus, whooping cough, Hepatitis B, and Haemophilic influenza. But ‘manufacturing defects’ in the vaccine can prove fatal too. Five children lost their lives in Sri Lanka last year after being inoculated with vaccines with similar suspended particles.

    Alarmingly, the defective lot of vaccines was distributed across 25 districts in the country between April-November last year and in the remaining 50 districts after November. There is no record of how many children have been inoculated with the potentially dangerous concoction. Government health experts are breathing a sign of relief as the vaccine seems to have done no significant harm — no dangerous side-effect of the vaccine has been reported in the country so far. They have also been quick to point the finger at the international agencies involved in vaccine import.

    It cannot be a coincidence, in their view, that vaccines from the same faulty batch were dispatched to many African countries, thus fanning the age-old suspicion of the rich world trying to ‘experiment’ on poor people. To its credit, WHO has vowed to replace all 131,000 old vials, which emanated from an Indian manufacturer, with a new lot from a South Korean manufacturer.

    The vaccine scandal comes hot on the heels of another infamous incident involving a UN agency, the World Food Programme (WFP). Last August, the Department of Food Technology and Quality Control found the foodstuff supplied by WFP in the Mid West to be ‘inedible’. As we have said in this space before, Nepali officials as well as politicians are quick to blame international organisations working in the country in order to hide their own failings. While we maintain that position, it would also be unwise (and potentially dangerous) to ignore genuine mistakes, made willingly or otherwise, of world bodies like WHO, which has, as in the latest vaccine case, undoubtedly failed to live up to its high standard of quality control.

    As of this writing, WHO is reportedly looking into the incident. It is vital for its credibility that it gets to the heart of the matter, make the findings of the investigation public and punish the guilty for a grave error — one which put the lives of countless Nepali children in danger. Meanwhile, the process of replacement of the old lot, which has already been delayed by a week, needs to be expedited so that the children scheduled to take their periodic dose do not miss their vaccination deadlines.

    www.ekantipur.com/the-kathmandu-post/...
  9. [verwijderd] 13 april 2010 21:29
    Vaccine from SKorea
    Last Updated : 2010-04-12 11:26 PM

    Himalayn News Services
    KATHMANDU: Ministry of Health and Population (MoHP) has received its first batch of Penta Vaccine from Crucell Berna Company today.
    Krishna Bahadur Chand, chief of Immunisation Programme at Child Health Division, said that the country received 131,600 vials of Quinvaxem, a pediatric vaccine, for one month from a South Korea-based company.
    The distribution of the vaccine had been temporarily halted since March 24 after Global Alliance for Vaccines and Immunization decided to replace Indian vaccines.

    www.thehimalayantimes.com/fullTodays....

    ---------------------------------------------------

    First batch: 131.600
    For one month
209 Posts
Pagina: «« 1 ... 6 7 8 9 10 11 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.848
AB InBev 2 5.308
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 47.062
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 9.032
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 32
Adomos 1 126
AdUX 2 457
Adyen 13 16.613
Aedifica 2 832
Aegon 3.257 320.327
AFC Ajax 537 7.026
Affimed NV 2 5.778
ageas 5.843 109.785
Agfa-Gevaert 13 1.897
Ahold 3.536 74.015
Air France - KLM 1.024 34.390
AIRBUS 1 1
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.778
Alfen 13 17.220
Allfunds Group 3 1.236
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 341
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.771
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.476
AMG 965 126.529
AMS 3 73
Amsterdam Commodities 303 6.527
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 383
Antonov 22.632 153.605
Aperam 91 14.190
Apollo Alternative Assets 1 17
Apple 5 322
Arcadis 251 8.628
Arcelor Mittal 2.024 318.766
Archos 1 1
Arcona Property Fund 1 269
arGEN-X 15 9.182
Aroundtown SA 1 186
Arrowhead Research 5 9.312
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.770
ASML 1.762 77.592
ASR Nederland 18 4.162
ATAI Life Sciences 1 7
Atenor Group 1 339
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.782
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 21 mei

    1. Envipco Q1-cijfers
    2. Fagron ex €0,30 dividend
    3. Euronext ex €2,48 dividend
    4. Shell jaarvergadering in Londen
    5. Handelsbalans maart (eurozone)
    6. Lowe's Q1-cijfers
    7. Macy's Q1-cijfers
    8. Pharming jaarvergadering
  2. 22 mei

    1. Aalberts Q1-cijfers
    2. Prijzen bestaande koopwoningen april (NL)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht